These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3041996)

  • 1. Cardiovascular effects of neuropeptide Y.
    Waeber B; Aubert JF; Corder R; Evéquoz D; Nussberger J; Gaillard R; Brunner HR
    Am J Hypertens; 1988 Apr; 1(2):193-9. PubMed ID: 3041996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuropeptide Y in cardiovascular regulation.
    Walker P; Grouzmann E; Burnier M; Waeber B
    Trends Pharmacol Sci; 1991 Mar; 12(3):111-5. PubMed ID: 2053188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y: a possible role in hypertension?
    Michel MC; Rascher W
    J Hypertens; 1995 Apr; 13(4):385-95. PubMed ID: 7629398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localisation of neuropeptide Y in nerves of the rat cardiovascular system and the effect of 6-hydroxydopamine.
    Allen JM; Polak JM; Rodrigo J; Darcy K; Bloom SR
    Cardiovasc Res; 1985 Sep; 19(9):570-7. PubMed ID: 3930070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and activity of dogfish NPY and peptide YY in the cardiovascular system of the common dogfish.
    Bjenning C; Hazon N; Balasubramaniam A; Holmgren S; Conlon JM
    Am J Physiol; 1993 Jun; 264(6 Pt 2):R1119-24. PubMed ID: 8322964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers.
    Fuxe K; Härfstrand A; Agnati LF; Kalia M; Fredholm B; Svensson T; Gustafsson JA; Lang R; Ganten D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S1-13. PubMed ID: 2455156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of neuropeptide Y on the rat adrenal cortex.
    Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
    Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor.
    Zukowska-Grojec Z
    Adv Pharmacol; 1998; 42():125-8. PubMed ID: 9327862
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
    Zukowska Z; Pons J; Lee EW; Li L
    Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated.
    Zukowska-Grojec Z; Shen GH; Capraro PA; Vaz CA
    Physiol Behav; 1991 Apr; 49(4):771-7. PubMed ID: 1881983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat.
    Pham TM; de Champlain J; Couture R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):42-9. PubMed ID: 8446182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
    Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
    Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropeptide Y and autonomic nervous system].
    Nozdrachev AD; Masliukov PM
    Zh Evol Biokhim Fiziol; 2011; 47(2):105-12. PubMed ID: 21598694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPY and related substances.
    McDonald JK
    Crit Rev Neurobiol; 1988; 4(1):97-135. PubMed ID: 2848631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y release from the adrenal medulla after cholinergic receptor stimulation.
    Hexum TD; Majane EA; Russett LR; Yang HY
    J Pharmacol Exp Ther; 1987 Dec; 243(3):927-30. PubMed ID: 2891838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y is an angiogenic factor in cardiovascular regeneration.
    Saraf R; Mahmood F; Amir R; Matyal R
    Eur J Pharmacol; 2016 Apr; 776():64-70. PubMed ID: 26875634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.